Alternative splicing in disease and therapy
The DOI matches its Crossref record; 193 of the 193 references it cites were found in a registry or an index.
Abstract
Alternative splicing is the major source of proteome diversity in humans and thus is highly relevant to disease and therapy. For example, recent work suggests that the long-sought-after target of the analgesic acetaminophen is a neural-specific, alternatively spliced isoform of cyclooxygenase 1 (COX-1). Several important diseases, such as cystic fibrosis, have been linked with mutations or variations in either cis-acting elements or trans-acting factors that lead to aberrant splicing and abnormal protein production. Correction of erroneous splicing is thus an important goal of molecular therapies. Recent experiments have used modified oligonucleotides to inhibit cryptic exons or to activate exons weakened by mutations, suggesting that these reagents could eventually lead to effective therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the occurrence of elastosis assumes an increase in elastic material in the photoaged skin, as observed in other studies [22, 56].”
From Elastin structure and its involvement in skin photoageing (2017) · cites this paper as [56]
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Harrison's Principles of Internal Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_2 · Cited by 12,514
Identification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,990
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Goedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Listening to silence and understanding nonsense: exonic mutations that affect splicing
Cartegni, L., Chew, S. L., & Krainer, A. R. (2002) · Nature Reviews Genetics · doi:10.1038/nrg775 · Cited by 2,209
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989
Human Gene Mutation Database (HGMD®): 2003 update: HGMD 2003 UPDATE
Stenson, P. D., Ball, E. V., Mort, M., Phillips, A. D., Shiel, J. A., Thomas, N. S. T., Abeysinghe, S., Krawczak, M., & Cooper, D. N. (2003) · Human Mutation · doi:10.1002/humu.10212 · Cited by 1,829
Zamecnik, P. C., & Stephenson, M. L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.280 · Cited by 1,792
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Hauβmann, I., Matzku, S., Wenzel, A., Ponta, H., & Herrlich, P. (1991) · Cell · doi:10.1016/0092-8674(91)90403-l · Cited by 1,654
Harrison's Principles of Internal Medicine
Freeman, D. L. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.286.8.971-a · Cited by 1,624
ESEfinder: a web resource to identify exonic splicing enhancers
Cartegni, L. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg616 · Cited by 1,603
Lorson, C. L., Hahnen, E., Androphy, E. J., & Wirth, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6307 · Cited by 1,532
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474
Genome-Wide Survey of Human Alternative Pre-mRNA Splicing with Exon Junction Microarrays
Johnson, J. M., Castle, J., Garrett-Engele, P., Kan, Z., Loerch, P. M., Armour, C. D., Santos, R., Schadt, E. E., Stoughton, R., & Shoemaker, D. D. (2003) · Science · doi:10.1126/science.1090100 · Cited by 1,418
Pre-mRNA splicing and human disease
Faustino, N. A., & Cooper, T. A. (2003) · Genes & Development · doi:10.1101/gad.1048803 · Cited by 1,256
Killing the messenger: short RNAs that silence gene expression
Dykxhoorn, D. M., Novina, C. D., & Sharp, P. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1129 · Cited by 1,182
Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134
Exon Recognition in Vertebrate Splicing
Berget, S. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2411 · Cited by 1,086
Sorting out the complexity of SR protein functions
GRAVELEY, B. R. (2000) · RNA · doi:10.1017/s1355838200000960 · Cited by 1,078
Lewis, B. P., Green, R. E., & Brenner, S. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0136770100 · Cited by 1,067
Goedert, M., Spillantini, M. G., Potier, M. C., Ulrich, J., & Crowther, R. A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03390.x · Cited by 1,037
Predictive Identification of Exonic Splicing Enhancers in Human Genes
Fairbrother, W. G., Yeh, R.-F., Sharp, P. A., & Burge, C. B. (2002) · Science · doi:10.1126/science.1073774 · Cited by 1,036
Mutation-Specific Functional Impairments in Distinct Tau Isoforms of Hereditary FTDP-17
Hong, M. (1998) · Science · doi:10.1126/science.282.5395.1914 · Cited by 1,003
Jurica, M. S., & Moore, M. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00270-3 · Cited by 962
Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy
Miller, J. W. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4439 · Cited by 937
Goedert, M., & Jakes, R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07870.x · Cited by 929
Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide.
Stephenson, M. L., & Zamecnik, P. C. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.285 · Cited by 906
Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma
Crozat, A., Åman, P., Mandahl, N., & Ron, D. (1993) · Nature · doi:10.1038/363640a0 · Cited by 894
A novel nuclear structure containing the survival of motor neurons protein.
Liu, Q., & Dreyfuss, G. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00725.x · Cited by 780
FLOWER, R. J., & VANE, J. R. (1972) · Nature · doi:10.1038/240410a0 · Cited by 779
Ou, S. H., Wu, F., Harrich, D., García-Martínez, L. F., & Gaynor, R. B. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3584-3596.1995 · Cited by 758
A Muscleblind Knockout Model for Myotonic Dystrophy
Kanadia, R. N., Johnstone, K. A., Mankodi, A., Lungu, C., Thornton, C. A., Esson, D., Timmers, A. M., Hauswirth, W. W., & Swanson, M. S. (2003) · Science · doi:10.1126/science.1088583 · Cited by 743
The survival motor neuron protein in spinal muscular atrophy
Coovert, D. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.8.1205 · Cited by 714
Buratti, E., & Baralle, F. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104236200 · Cited by 700
Alternative splicing: multiple control mechanisms and involvement in human disease
Cáceres, J. F., & Kornblihtt, A. R. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(01)02626-9 · Cited by 652
Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping
Buratti, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1774 · Cited by 631
Structure and novel exons of the human .tau. gene
Andreadis, A., Brown, W. M., & Kosik, K. S. (1992) · Biochemistry · doi:10.1021/bi00158a027 · Cited by 624
Charlet-B., N., Savkur, R. S., Singh, G., Philips, A. V., Grice, E. A., & Cooper, T. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00572-5 · Cited by 619
Regulation of Alternative Splicing in Vivo by Overexpression of Antagonistic Splicing Factors
Cáceres, J. F., Stamm, S., Helfman, D. M., & Krainer, A. R. (1994) · Science · doi:10.1126/science.8085156 · Cited by 618
A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy
Kashima, T., & Manley, J. L. (2003) · Nature Genetics · doi:10.1038/ng1207 · Cited by 546
Chu, C.-S., Trapnell, B. C., Curristin, S., Cutting, G. R., & Crystal, R. G. (1993) · Nature Genetics · doi:10.1038/ng0293-151 · Cited by 523
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2
Krämer, O. H., Zhu, P., Ostendorff, H. P., Golebiewski, M., Tiefenbach, J., Peters, M. A., Brill, B., Groner, B., Bach, I., Heinzel, T., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg315 · Cited by 523 · cited 1×
“Butyrate and valproic acid inhibit histone deacetylases (HDAC), and this inhibition in turn leads to increased transcription of many genes (see ref”
BackgroundModrek, B., & Lee, C. J. (2003) · Nature Genetics · doi:10.1038/ng1159 · Cited by 522
D’Souza, I., Poorkaj, P., Hong, M., Nochlin, D., Lee, V. M.-Y., Bird, T. D., & Schellenberg, G. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5598 · Cited by 515
The microtubule binding domain of tau protein
Lee, G., Neve, R. L., & Kosik, K. S. (1989) · Neuron · doi:10.1016/0896-6273(89)90050-0 · Cited by 500 · cited 1×
“In the C-terminal half, exons 9–12 encode four microtubule-binding domains that are imperfect repeats of 31 or 32 amino acid”
BackgroundMa, K., Inglis, J. D., Sharkey, A., Bickmore, W. A., Hill, R. E., Prosser, E. J., Speed, R. M., Thomson, E. J., Jobling, M., Taylor, K., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90616-x · Cited by 499
Splicing double: insights from the second spliceosome
Patel, A. A., & Steitz, J. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1259 · Cited by 478
Clark, L. N., Poorkaj, P., Wszolek, Z., Geschwind, D. H., Nasreddine, Z. S., Miller, B., Li, D., Payami, H., Awert, F., Markopoulou, K., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13103 · Cited by 474
Lovestone, S., Reynolds, C. H., Latimer, D., Davis, D. R., Anderton, B. H., Gallo, J.-M., Hanger, D., Mulot, S., Marquardt, B., Stabel, S., et al. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00246-3 · Cited by 469
Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides.
Dominski, Z., & Kole, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8673 · Cited by 426
Nova-1 Regulates Neuron-Specific Alternative Splicing and Is Essential for Neuronal Viability
Jensen, K. B., Dredge, B. K., Stefani, G., Zhong, R., Buckanovich, R. J., Okano, H. J., Yang, Y. Y. L., & Darnell, R. B. (2000) · Neuron · doi:10.1016/s0896-6273(00)80900-9 · Cited by 426
Progress in antisense technology
Crooke, S. T. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104408 · Cited by 417 · cited 1×
“Oligonucleotide-mediated therapies Gene-specific therapy can be mediated by oligonucleotides or oligonucleotide-like compounds, some of which have been shown to have clinical effectiveness in other application”
BackgroundWollerton, M. C., Gooding, C., Wagner, E. J., Garcia-Blanco, M. A., & Smith, C. W. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(03)00502-1 · Cited by 409
Treatment of spinal muscular atrophy by sodium butyrate
Chang, J.-G., Hsieh-Li, H.-M., Jong, Y.-J., Wang, N. M., Tsai, C.-H., & Li, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171105098 · Cited by 404
Yan, G., Fukabori, Y., McBride, G., Nikolaropolous, S., & McKeehan, W. L. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4513 · Cited by 403
Catalytic topoisomerase II inhibitors in cancer therapy
Larsen, A. K., Escargueil, A. E., & Skladanowski, A. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00058-5 · Cited by 398
Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse
Lu, Q. L., Mann, C. J., Lou, F., Bou-Gharios, G., Morris, G. E., Xue, S.-A., Fletcher, S., Partridge, T. A., & Wilton, S. D. (2003) · Nature Medicine · doi:10.1038/nm897 · Cited by 398
Cuppens, H., Lin, W., Jaspers, M., Costes, B., Teng, H., Vankeerberghen, A., Jorissen, M., Droogmans, G., Reynaert, I., Goossens, M., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci639 · Cited by 397
Zhu, J., Mayeda, A., & Krainer, A. R. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00409-9 · Cited by 394
Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse
Mann, C. J., Honeyman, K., Cheng, A. J., Ly, T., Lloyd, F., Fletcher, S., Morgan, J. E., Partridge, T. A., & Wilton, S. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.42 · Cited by 388
Brichta, L. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg256 · Cited by 382
The spliceosome: the most complex macromolecular machine in the cell?
Nilsen, T. W. (2003) · BioEssays · doi:10.1002/bies.10394 · Cited by 378
Polypyrimidine Tract Binding Protein Antagonizes Exon Definition
Wagner, E. J., & Garcia-Blanco, M. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3281-3288.2001 · Cited by 375
A computational analysis of sequence features involved in recognition of short introns
Lim, L. P., & Burge, C. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201407298 · Cited by 374
The Phenotypic Consequences of CFTR Mutations
Rowntree, R. K., & Harris, A. (2003) · Annals of Human Genetics · doi:10.1046/j.1469-1809.2003.00028.x · Cited by 346
Clark, J., Lu, Y.-J., Sidhar, S. K., Parker, C., Gill, S., Smedley, D., Hamoudi, R., Linehan, W. M., Shipley, J., & Cooper, C. S. (1997) · Oncogene · doi:10.1038/sj.onc.1201394 · Cited by 344
Chalfant, C. E., Rathman, K., Pinkerman, R. L., Wood, R. E., Obeid, L. M., Ogretmen, B., & Hannun, Y. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112010200 · Cited by 337
Vithana, E. N., Abu-Safieh, L., Allen, M. J., Carey, A., Papaioannou, M., Chakarova, C., Al-Maghtheh, M., Ebenezer, N. D., Willis, C., Moore, A. T., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00305-7 · Cited by 335
Local gene knockdown in the brain using viral-mediated RNA interference
Hommel, J. D., Sears, R. M., Georgescu, D., Simmons, D. L., & DiLeone, R. J. (2003) · Nature Medicine · doi:10.1038/nm964 · Cited by 334
Buckanovich, R. J., Posner, J. B., & Darnell, R. B. (1993) · Neuron · doi:10.1016/0896-6273(93)90077-5 · Cited by 319
Emerging clinical applications of RNA
Sullenger, B. A., & Gilboa, E. (2002) · Nature · doi:10.1038/418252a · Cited by 318
Valcárcel, J., Singh, R., Zamore, P. D., & Green, M. R. (1993) · Nature · doi:10.1038/362171a0 · Cited by 313
Manipulation of Alternative Splicing by a Newly Developed Inhibitor of Clks
Muraki, M., Ohkawara, B., Hosoya, T., Onogi, H., Koizumi, J., Koizumi, T., Sumi, K., Yomoda, J.-I., Murray, M. V., Kimura, H., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314298200 · Cited by 308
Evolutionary Fates and Origins of U12-Type Introns
Burge, C. B., Padgett, R. A., & Sharp, P. A. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80292-0 · Cited by 304
Systemically delivered antisense oligomers upregulate gene expression in mouse tissues
Sazani, P., Gemignani, F., Kang, S.-H., Maier, M. A., Manoharan, M., Persmark, M., Bortner, D., & Kole, R. (2002) · Nature Biotechnology · doi:10.1038/nbt759 · Cited by 301
Correction of disease-associated exon skipping by synthetic exon-specific activators
Cartegni, L., & Krainer, A. R. (2003) · Nature Structural Biology · doi:10.1038/nsb887 · Cited by 301
How prevalent is functional alternative splicing in the human genome?
Sorek, R., Shamir, R., & Ast, G. (2004) · Trends in Genetics · doi:10.1016/j.tig.2003.12.004 · Cited by 301
Grover, A., Houlden, H., Baker, M., Adamson, J., Lewis, J., Prihar, G., Pickering-Brown, S., Duff, K., & Hutton, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.15134 · Cited by 299
Lynch, T., Sano, M., Marder, K. S., Bell, K. L., Foster, N. L., Defending, R. F., Sima, A. A. F., Keohane, C., Nygaard, T. G., Fahn, S., et al. (1994) · Neurology · doi:10.1212/wnl.44.10.1878 · Cited by 288
McKie, A. B. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.15.1555 · Cited by 282
Skordis, L. A., Dunckley, M. G., Yue, B., Eperon, I. C., & Muntoni, F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0633863100 · Cited by 274
Ribozyme-mediated repair of defective mRNA by targeted trans-splicing
Sullenger, B. A., & Cech, T. R. (1994) · Nature · doi:10.1038/371619a0 · Cited by 266
Ichikawa, H., Shimizu, K., Hayashi, Y., & Ohki, M. (1994) · PubMed · Cited by 255
Dunckley, M. G., Manoharan, M., Villiet, P., Eperon, I. C., & Dickson, G. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.7.1083 · Cited by 255
Varani, L., Hasegawa, M., Spillantini, M. G., Smith, M. J., Murrell, J. R., Ghetti, B., Klug, A., Goedert, M., & Varani, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8229 · Cited by 247
Chakarova, C. F. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.1.87 · Cited by 243
β+ Thalassemia: Aberrant splicing results from a single point mutation in an intron
Busslinger, M., Moschonas, N., & Flavell, R. A. (1981) · Cell · doi:10.1016/0092-8674(81)90412-8 · Cited by 232
Andreassi, C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.24.2841 · Cited by 229
Base substitution in an intervening sequence of a beta+-thalassemic human globin gene.
Spritz, R. A., Jagadeeswaran, P., Choudary, P. V., Biro, P. A., Elder, J. T., deRiel, J. K., Manley, J. L., Gefter, M. L., Forget, B. G., & Weissman, S. M. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2455 · Cited by 228
Splicing regulation as a potential genetic modifier
Nissim-Rafinia, M., & Kerem, B. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(01)02619-1 · Cited by 224
hnRNP A1 Recruited to an Exon In Vivo Can Function as an Exon Splicing Silencer
Del Gatto-Konczak, F., Olive, M., Gesnel, M.-C., & Breathnach, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.251 · Cited by 224
Arginine/Serine-Rich Domains of SR Proteins Can Function as Activators of Pre-mRNA Splicing
Graveley, B. R., & Maniatis, T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80076-3 · Cited by 217
Wilton, S. D., Lloyd, F., Carville, K., Fletcher, S., Honeyman, K., Agrawal, S., & Kole, R. (1999) · Neuromuscular Disorders · doi:10.1016/s0960-8966(99)00010-3 · Cited by 217
Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing
Sazani, P., & Kole, R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19547 · Cited by 207
Gatto–Konczak, F. D., Bourgeois, C. F., Guiner, C. L., Kister, L., Gesnel, M.-C., Stévenin, J., & Breathnach, R. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.17.6287-6299.2000 · Cited by 202
Chou, M.-Y., Underwood, J. G., Nikolic, J., Luu, M. H. T., & Black, D. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80260-9 · Cited by 198
Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing
Sazani, P., & Kole, R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319547 · Cited by 198
Taylor, J. K., Zhang, Q. Q., Wyatt, J. R., & Dean, N. M. (1999) · Nature Biotechnology · doi:10.1038/15079 · Cited by 197
Spliceosome-mediated RNA trans-splicing as a tool for gene therapy
Puttaraju, M., Jamison, S. F., Mansfield, S. G., Garcia-Blanco, M. A., & Mitchell, L. G. (1999) · Nature Biotechnology · doi:10.1038/6986 · Cited by 197
Maquat, L. E. (2006) · CRC Press eBooks · doi:10.1201/9781498713399 · Cited by 191
Small RNA: can RNA interference be exploited for therapy?
Wall, N. R., & Shi, Y. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14637-5 · Cited by 180
A systematic analysis of the factors that determine the strength of pre-mRNA splicing enhancers
Graveley, B. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6747 · Cited by 176
Pagani, F., Buratti, E., Stuani, C., Romano, M., Zuccato, E., Niksic, M., Giglio, L., Faraguna, D., & Baralle, F. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910165199 · Cited by 175
Liu, X., Jiang, Q., Mansfield, S. G., Puttaraju, M., Zhang, Y., Zhou, W., Cohn, J. A., Garcia-Blanco, M. A., Mitchell, L. G., & Engelhardt, J. F. (2002) · Nature Biotechnology · doi:10.1038/nbt0102-47 · Cited by 174
CD44v6: a target for antibody-based cancer therapy
Heider, K.-H., Kuthan, H., Stehle, G., & Munzert, G. (2004) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-003-0494-4 · Cited by 173
Goldstrohm, A. C., Greenleaf, A. L., & Garcia-Blanco, M. A. (2001) · Gene · doi:10.1016/s0378-1119(01)00695-3 · Cited by 166
Friedman, K. J., Kole, J., Cohn, J. A., Knowles, M. R., Silverman, L. M., & Kole, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36193 · Cited by 166
Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing
Chao, H., Mansfield, S. G., Bartel, R. C., Hiriyanna, S., Mitchell, L. G., Garcia-Blanco, M. A., & Walsh, C. E. (2003) · Nature Medicine · doi:10.1038/nm900 · Cited by 164
Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9.
Nikšić, M., Romano, M., Buratti, E., Pagani, F., & Baralle, F. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.13.2339 · Cited by 164
Intrinsic differences between authentic and cryptic 5' splice sites
Roca, X. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg830 · Cited by 160
Lacerra, G., Sierakowska, H., Carestia, C., Fucharoen, S., Summerton, J., Weller, D., & Kole, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9591 · Cited by 159
Roberts, R., Timchenko, N. A., Miller, J. W., Reddy, S., Caskey, C. T., Swanson, M. S., & Timchenko, L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13221 · Cited by 156
Noone, P. G., & Knowles, M. R. (2001) · Respiratory Research · doi:10.1186/rr82 · Cited by 153
Costes, B., Girodon, E., Ghanem, N., Flori, E., Jardin, A., Soufir, J.-C., & Goossens, M. (1995) · European Journal of Human Genetics · doi:10.1159/000472312 · Cited by 147
Assessing the Impact of Alternative Splicing on Domain Interactions in the Human Proteome
Resch, A. M., Xing, Y., Modrek, B., Gorlick, M. M., Riley, R. W., & Lee, C. J. (2003) · Journal of Proteome Research · doi:10.1021/pr034064v · Cited by 144
TLS-ERG Leukemia Fusion Protein Inhibits RNA Splicing Mediated by Serine-Arginine Proteins
Yang, L., Embree, L. J., & Hickstein, D. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.10.3345-3354.2000 · Cited by 143
Pagani, F., Buratti, E., Stuani, C., & Baralle, F. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212813200 · Cited by 141
Hernández, F., Pérez, M., Lucas, J. J., Mata, A. M., Bhat, R. V., & Ávila, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311512200 · Cited by 140
Jiang, Z., Côté, J., Kwon, J. M., Goate, A., & Wu, J. Y. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4036-4048.2000 · Cited by 137
SCNM1, a Putative RNA Splicing Factor That Modifies Disease Severity in Mice
Buchner, D. A., Trudeau, M., & Meisler, M. H. (2003) · Science · doi:10.1126/science.1086187 · Cited by 137
Angelis, F. G. D., Sthandier, O., Berarducci, B., Toso, S., Galluzzi, G., Ricci, E., Cossu, G., & Bozzoni, I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142302299 · Cited by 136
Zhang, X. H.-F. (2003) · Genome Research · doi:10.1101/gr.1679003 · Cited by 134
Auboeuf, D., Dowhan, D. H., Kang, Y. K., Larkin, K., Lee, J. W., Berget, S. M., & O’Malley, B. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308133100 · Cited by 131
Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia
Stanford, P. M. (2003) · Brain · doi:10.1093/brain/awg090 · Cited by 131
Guiner, C. L., Lejeune, F., Galiana-Arnoux, D., Kister, L., Breathnach, R., Stévenin, J., & Gatto–Konczak, F. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105642200 · Cited by 128
Venables, J. P., Elliott, D. J., Makarova, O. V., Makarov, E. M., Cooke, H. J., & Eperon, I. C. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.5.685 · Cited by 126
Helmken, C., Hofmann, Y., Schoenen, F. J., Oprea, G. E., Raschke, H., Rudnik-Sch�neborn, S., Zerres, K., & Wirth, B. (2003) · Human Genetics · doi:10.1007/s00439-003-1025-2 · Cited by 125
Stable alteration of pre-mRNA splicing patterns by modified U7 small nuclear RNAs
Gorman, L. Z., Suter, D., Emerick, V. L., Schümperli, D., & Kole, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.4929 · Cited by 124
Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
Spillantini, M. G., Swieten, J. C. V., & Goedert, M. (2000) · PubMed · doi:10.1007/pl00022972 · Cited by 122
Imai, H., Chan, E. K. L., Kiyosawa, K., Fu, X., & Tan, E. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116848 · Cited by 122
Human Genomic Sequences That Inhibit Splicing
Fairbrother, W. G., & Chasin, L. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6816-6825.2000 · Cited by 121
Lu, X., Timchenko, N. A., & Timchenko, L. T. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.1.53 · Cited by 120
An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy
Singh, N. N., Androphy, E. J., & Singh, R. N. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.067 · Cited by 117
Kalbfuss, B., Mabon, S. A., & Misteli, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105113200 · Cited by 116
Millar, D. S., Lewis, M. D., Horan, M. P., Newsway, V., Easter, T. E., Gregory, J. W., Fryklund, L., Norin, M., Crowne, E. C., Davies, S. J., et al. (2003) · Human Mutation · doi:10.1002/humu.10168 · Cited by 114
Jiang, Z., Tang, H., Havlioglu, N., Zhang, X., Stamm, S., Yan, R., & Wu, J. Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301800200 · Cited by 112
Maquat, L. E. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00747-9 · Cited by 111
Higher Proportion of Intact Exon 9 CFTR mRNA in Nasal Epithelium Compared with Vas Deferens
Mak, V., Jarvi, K. A., Zielenski, J., Durie, P. R., & Tsui, L. ‐. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.12.2099 · Cited by 106
Horabin, J. I., & Schedl, P. D. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7734-7746.1993 · Cited by 104
Carstens, R. P., McKeehan, W. L., & García-Blanco, M. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.2205 · Cited by 102
Exon-specific RNAi: A tool for dissecting the functional relevance of alternative splicing
Celotto, A. M., & Graveley, B. R. (2002) · RNA · doi:10.1017/s1355838202021064 · Cited by 94
Chiba‐Falek, O., Kerem, E., Shoshani, T., Aviram, M., Augarten, A., Bentur, L., Tal, A., Tullis, E., Rahat, A., & Kerem, B.-S. (1998) · Genomics · doi:10.1006/geno.1998.5517 · Cited by 92
Baraniak, A. P., Lasda, E. L., Wagner, E. J., & García-Blanco, M. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9327-9337.2003 · Cited by 91
Self-citationFomenkov, A. I., Huang, Y., Topaloglu, Ö., Brechman, A., Osada, M., Fomenkova, T. E., Yuriditsky, E., Trink, B., Sidransky, D., & Ratovitski, E. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300746200 · Cited by 90
Cell-Specific RNA-Binding Proteins in Human Disease
Musunuru, K. (2003) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(03)00075-6 · Cited by 90
Daoud, R., Mies, G., Smialowska, A., Oláh, L., Hossmann, K.-A., & Stamm, S. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-14-05889.2002 · Cited by 90
COX-3: a splice variant of cyclooxygenase-1 in mouse neural tissue and cells
Shaftel, S. S., Olschowka, J. A., Hurley, S. D., Moore, A. H., & O’Banion, M. K. (2003) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.09.006 · Cited by 89
Complex Regulation of Tau Exon 10, Whose Missplicing Causes Frontotemporal Dementia
Gao, Q., Memmott, J. E., Lafyatis, R., Stamm, S., Screaton, G. R., & Andreadis, A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740490.x · Cited by 88
Functional repair of a mutant chloride channel using a trans-splicing ribozyme
Rogers, C. S., Vanoye, C. G., Sullenger, B. A., & George, A. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200216481 · Cited by 86
Gatto–Konczak, F. D., Plet, A., Gesnel, M.-C., Fort, C., & Breathnach, R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5106 · Cited by 85
The relevance of alternative RNA splicing to pharmacogenomics
Bracco, L. P., & Kearsey, J. (2003) · Trends in biotechnology · doi:10.1016/s0167-7799(03)00146-x · Cited by 82
Haemophilia B caused by a point mutation in a donor splice junction of the human factor IX gene
Rees, D. J. G., Rizza, C. R., & Brownlee, G. G. (1985) · Nature · doi:10.1038/316643a0 · Cited by 81
Teng, H. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.1.85 · Cited by 81
Manabe, T., Katayama, T., Sato, N., Gomi, F., Hitomi, J., Yanagita, T., Kudo, T., Honda, A., Mori, Y., Matsuzaki, S., et al. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401221 · Cited by 79
Zuccato, E., Buratti, E., Stuani, C., Baralle, F. E., & Pagani, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313439200 · Cited by 78
Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing
García-Blanco, M. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19462 · Cited by 75
Testicular CFTR Splice Variants in Patients with Congenital Absence of the Vas Deferens
Larriba, S., Bassas, L., Gimenez, J., Ramos, M. D. B., Segura, A., Nunes, V., Estivill, X., & Casals, T. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.11.1739 · Cited by 75
Villemaire, J., Dion, I., Elela, S. A., & Chabot, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308897200 · Cited by 74
Karras, J. G., Maier, M. A., Lü, T., Watt, A. T., & Manoharan, M. (2001) · Biochemistry · doi:10.1021/bi010263l · Cited by 70
Isoherranen, N., Yagen, B., & Bialer, M. (2003) · Current Opinion in Neurology · doi:10.1097/01.wco.0000063774.81810.30 · Cited by 69
Nissim‐Rafinia, M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.12.1771 · Cited by 68
Isoherranen, N., Yagen, B., & Bialer, M. (2003) · Current Opinion in Neurology · doi:10.1097/00019052-200304000-00014 · Cited by 68
Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease
Atweh, G. F., & Schechter, A. N. (2001) · Current Opinion in Hematology · doi:10.1097/00062752-200103000-00010 · Cited by 66
Aznarez, I. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg215 · Cited by 65
Maquat, L. E., Kinniburgh, A. J., Beach, L. R., Honig, G. R., Lazerson, J., Ershler, W. B., & Ross, J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.4287 · Cited by 64
Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing
García-Blanco, M. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319462 · Cited by 63
Ryther, R. C. C., McGuinness, L., Phillips, J. A., Moseley, C. T., Magoulas, C., Robinson, I. C. A. F., & Patton, J. G. (2003) · Human Genetics · doi:10.1007/s00439-003-0949-x · Cited by 61
Goedert, M., Ghetti, B. F., & Spillantini, M. G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06907.x · Cited by 60
Vacek, M. M., Ma, H., Gemignani, F., Lacerra, G., Kafri, T., & Kole, R. (2002) · Blood · doi:10.1182/blood-2002-06-1869 · Cited by 56
Variants of cyclooxygenase-1 and their roles in medicine
Simmons, D. L. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00380-3 · Cited by 56
Interferons and IRF-1 Induce Expression of the Survival Motor Neuron (SMN) Genes
Baron-Delage, S., Abadie, A., Echaniz‐Laguna, A., Melki, J., & Beretta, L. (2000) · Molecular Medicine · doi:10.1007/bf03401830 · Cited by 55
Jones, R. B., Wang, F., Luo, Y., Yu, C., Jin, C., Suzuki, T., Kan, M., & McKeehan, W. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006151200 · Cited by 55
Effects on splicing and protein function of three mutations in codon N296 of tau in vitro
Grover, A., DeTure, M., Yen, S.-H., & Hutton, M. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00124-6 · Cited by 53
Mercatante, D. R., Sazani, P., & Kole, R. (2001) · Current Cancer Drug Targets · doi:10.2174/1568009013334124 · Cited by 52
Horabin, J. I., & Schedl, P. D. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7734 · Cited by 50
Miné, M., Brivet, M., Touati, G., Grabowski, P. J., Abitbol, M. M., & Marsac, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211106200 · Cited by 48
Atypical 5′ Splice Sites Cause CFTR Exon 9 To Be Vulnerable to Skipping
Hefferon, T. W., Broackes-Carter, F. C., Harris, A., & Cutting, G. R. (2002) · The American Journal of Human Genetics · doi:10.1086/341664 · Cited by 47
Tolnay, M., Spillantini, M. G., Rizzini, C., Eccles, D., Lowe, J. S., & Ellison, D. H. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2000.00109.x · Cited by 41
Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)
Spillantini, M. G., Van Swieten, J. C., & Goedert, M. (2000) · Neurogenetics · doi:10.1007/s100489900084 · Cited by 33
Extensive Exon Reshuffling Over Evolutionary Time Coupled to Trans -Splicing in DrosophilaPreprint
Labrador, M., & Corces, V. G. (2003) · Genome Research · doi:10.1101/gr.1440703 · Cited by 30
An archaeal endoribonuclease catalyzes cis- and trans- nonspliceosomal splicing in mouse cells
Deidda, G., Rossi, N., & Tocchini‐Valentini, G. P. (2003) · Nature Biotechnology · doi:10.1038/nbt908 · Cited by 26
RNA repair: a novel approach to gene therapy
Watanabe, T., & Sullenger, B. A. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00089-2 · Cited by 24
Bingham, C. O. (2002) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.69.suppl_1.si5 · Cited by 23
Quantification of alternatively spliced FGFR2 RNAs using the RNA invasive cleavage assay
Wagner, E. J., Curtis, M. L., Robson, N. D., Baraniak, A. P., Eis, P. S., & García-Blanco, M. A. (2003) · RNA · doi:10.1261/rna.5840803 · Cited by 23
Self-citationFamilial Frontotemporal Dementia: From Gene Discovery to Clinical Molecular Diagnostics
Deerlin, V. M. V., Gill, L. H., Farmer, J. M., Trojanowski, J. Q., & Lee, V. M. ‐. (2003) · Clinical Chemistry · doi:10.1373/49.10.1717 · Cited by 21
A novel mutation at position +11 in the intron following exon 10 of the tau gene in FTDP-17.
Kowalska, A., Hasegawa, M., Miyamoto, K., Akiguchi, I., Ikemoto, A., Takahashi, K., Araki, W., & Tabira, T. (2002) · PubMed · Cited by 20
SMN2-deletion in childhood-onset spinal muscular atrophy
Srivastava, S., Mukherjee, M., Panigrahi, I., Pandey, G. S., Pradhan, S., & Mittal, B. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1386 · Cited by 18
Can a ‘patch’ in a skipped exon make the pre-mRNA splicing machine run better?
Buratti, E., Baralle, F. E., & Pagani, F. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00072-8 · Cited by 16
Putting some spine into alternative splicing
Khoo, B. C. E., Akker, S. A., & Chew, S. L. (2003) · Trends in biotechnology · doi:10.1016/s0167-7799(03)00168-9 · Cited by 8
Eperon, I. C., & Francesco Muntoni, A. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00068-6 · Cited by 6
The Phosphoryl Transfer Reactions in Pre-Messenger RNA Splicing
García-Blanco, M. A., Lindsey‐Boltz, L. A., & Ghosh, S. (2001) · Elsevier eBooks · doi:10.1016/b978-008043408-7/50028-9 · Cited by 4
Cited by
Analyses of pig genomes provide insight into porcine demography and evolution
Groenen, M. A. M., Archibald, A. L., Uenishi, H., Tuggle, C. K., Takeuchi, Y., Rothschild, M. F., Rogel-Gaillard, C., Park, C., Milan, D., Megens, H.-J., et al. (2012) · Nature · doi:10.1038/nature11622 · Cited by 1,385
Gene co-expression analysis for functional classification and gene–disease predictions
van Dam, S., Võsa, U., van der Graaf, A., Franke, L., & de Magalhães, J. P. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbw139 · Cited by 995
Alternative splicing and evolution: diversification, exon definition and function
Keren, H., Lev-Maor, G., & Ast, G. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2776 · Cited by 1,082
RNA splicing is a primary link between genetic variation and disease
Li, Y. I., van de Geijn, B., Raj, A., Knowles, D. A., Petti, A. A., Golan, D., Gilad, Y., & Pritchard, J. K. (2016) · Science · doi:10.1126/science.aad9417 · Cited by 660
for the Multiple Sclerosis Genetics Group, Gregory, S. G., Schmidt, S., Seth, P., Oksenberg, J. R., Hart, J., Prokop, A., Caillier, S. J., Ban, M., Goris, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2103 · Cited by 657
Metadata
- Authors
- Garcia-Blanco, M. A., Baraniak, A. P., & Lasda, E. L.
- Affiliations
- Duke University (US)
- ORCID
- Lasda, Erika L
- Venue
- Nature Biotechnology
- Published
- 2004-05
- Volume
- 22
- Issue
- 5
- Pages
- 535-546
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2070564797
- Cited by
- 527
- References
- 192
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 9 · 2023: 16 · 2022: 13 · 2021: 10 · 2020: 14 · 2019: 15 · 2018: 18 · 2017: 19 · 2016: 16 · 2015: 21 · 2014: 20 · 2013: 28 · 2012: 33
- FWCI
- 16.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R33CA097502, R33 CA97502)
- National Institute of General Medical Sciences (R01GM063090, R01 GM 63090)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- alternative splicing, proteome diversity, cystic fibrosis, aberrant splicing, cis-regulatory elements, trans-acting splicing factors, cyclooxygenase-1, paracetamol, cryptic exons, modified oligonucleotides, splicing correction, molecular therapy
- MeSH terms
- Base Sequence, Humans, Phenotype, RNA, Therapeutics, Alternative Splicing, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.